about
Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target.Mapping Novel Metabolic Nodes Targeted by Anti-Cancer Drugs that Impair Triple-Negative Breast Cancer Pathogenicity.HIF-1α Is an Essential Mediator of IFN-γ-Dependent Immunity to Mycobacterium tuberculosis.Chemoproteomics-Enabled Covalent Ligand Screening Reveals a Thioredoxin-Caspase 3 Interaction Disruptor That Impairs Breast Cancer Pathogenicity.Argininosuccinate Synthase 1 is a Metabolic Regulator of Colorectal Cancer Pathogenicity.Chemoproteomic Profiling of Acetanilide Herbicides Reveals Their Role in Inhibiting Fatty Acid Oxidation.NHS-Esters As Versatile Reactivity-Based Probes for Mapping Proteome-Wide Ligandable Hotspots.Novel K-Ras G12C Switch-II covalent binders destabilize Ras and accelerate nucleotide exchange.Deletion of Adipose Triglyceride Lipase links triacylglycerol accumulation to a more aggressive phenotype in A549 lung carcinoma cells.Discovery of Hydrolysis-Resistant Isoindoline N-Acyl Amino Acid Analogues that Stimulate Mitochondrial Respiration.The ER membrane protein complex promotes biogenesis of sterol-related enzymes maintaining cholesterol homeostasisCancer Metabolism: Current Understanding and TherapiesChemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy TargetER-lysosome contacts enable cholesterol sensing by mTORC1 and drive aberrant growth signalling in Niemann-Pick type CVirtual Issue on the Work of John CasidaCovalent targeting of the vacuolar H+-ATPase activates autophagy via mTORC1 inhibitionCovalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation ApplicationsHarnessing the anti-cancer natural product nimbolide for targeted protein degradation
P50
Q36276761-2E198CC3-6A81-4344-B12C-9E3CE5CE1BE8Q38714390-011599E9-3D0D-43CD-8073-AB889BAA0970Q40609000-115AA7FD-B00D-4A21-9119-7EE5F3028FA7Q46078956-F80DC0FB-8F5E-4425-AC3F-8AA4A76B2AB2Q46093612-78434C67-0732-4EA2-BF36-C45D08422536Q46245622-4C6129CD-F7BB-4E77-8860-8AD843694ECFQ46904372-C501D7D2-F042-48A7-BEB0-78FA992210A0Q47214042-24F15CBD-05B0-46A5-A4A7-16C25E8E7A5BQ49849732-485F68CA-9609-44D2-9508-B3CE53BC7494Q53702505-72805DC3-F886-445D-BA3E-E684DF187093Q61815236-0C37DE07-5E2C-4315-8C4E-FE20217D8B6CQ89230907-89E6C69D-BB0D-4947-BD61-FB44DBE04AC7Q90030000-67148E66-0BBB-4354-86B9-870F398E4F5DQ90242248-D0142218-EB83-40A7-8C95-0B3B57D28695Q90772026-533F33A0-2BAE-4E33-A0C1-962539A7A76EQ91723970-B2BF4B61-EDA6-4E74-B8EE-F478DA89D2F3Q91791036-2A44CA6F-03A8-4939-B1D3-15FF0CBE920AQ92826564-73688B45-8FCA-4367-B19D-F3DA5AC9566C
P50
description
researcher
@en
wetenschapper
@nl
name
Daniel K Nomura
@en
Daniel K Nomura
@nl
type
label
Daniel K Nomura
@en
Daniel K Nomura
@nl
prefLabel
Daniel K Nomura
@en
Daniel K Nomura
@nl
P31
P496
0000-0003-1614-8360